Lp(a)升高与颈动脉粥样硬化进展相关:3272人队列研究结果
Elevated lipoprotein(a) is associated with the progression of carotid atherosclerosis
日本国家脑血管病研究中心团队在European Journal of Preventive Cardiology发表研究,分析3272名基线无颈动脉斑块参与者的11.5年随访数据,发现Lp(a)≥50 mg/dL与颈动脉斑块形成及进展至≥50%狭窄的风险相关。多变量调整HR为1.27,OR超过2倍。
研究数据展示了Lp(a)水平与颈动脉粥样硬化不同阶段进展的相关性,读者可据此了解其在风险分层中的潜在作用。
Lipoprotein(a), or Lp(a), is a genetically determined blood lipid and an important risk factor for cardiovascular disease. However, its association with the long-term progression of carotid atherosclerosis has remained unclear, particularly in East Asian populations.
Researchers from the National Cerebral and Cardiovascular Center in Japan have shown that elevated Lp(a) is associated with multiple stages of carotid atherosclerosis, from carotid plaque development to its progression to carotid stenosis. The findings were published in the European Journal of Preventive Cardiology.
In this study, the research team analyzed 3,272 participants from the Suita Study who had no history of cardiovascular disease and no carotid plaque at baseline. Participants underwent repeated carotid ultrasound examinations every two years through June 2016. Lp(a) levels were categorized as <15, 15–29, 30–49 and ≥50 mg/dL.
During a median follow-up of 11.5 years, 1,432 participants developed a new carotid plaque. Compared with participants with Lp(a) <15 mg/dL, those with Lp(a) ≥50 mg/dL had a higher risk of carotid plaque development, with a multivariable-adjusted hazard ratio of 1.27. They also showed a faster annual progression of carotid intima-media thickness.
Among participants who developed carotid plaques, Lp(a) ≥50 mg/dL was associated with more than twice the odds of progression to ≥50% carotid stenosis.
"Our findings suggest that elevated Lp(a) is associated with the continuum of carotid atherosclerosis, from plaque initiation to luminal stenosis," said lead author Masayuki Teramoto. "Measuring Lp(a) may help identify individuals at an increased lifetime risk of atherosclerosis beyond conventional cardiovascular risk factors."
Although only about 5% of participants had Lp(a) ≥50 mg/dL, this group showed consistently higher risk across multiple stages of carotid atherosclerosis. These findings suggest that Lp(a) ≥50 mg/dL may be useful for risk stratification even in East Asian populations.
The study supports the importance of the early identification of individuals with elevated Lp(a) and the careful management of modifiable cardiovascular risk factors, including blood pressure, LDL cholesterol and diabetes.
Further studies are needed to determine whether emerging Lp(a)-lowering therapies can slow carotid atherosclerosis progression or prevent cardiovascular events.
Publication details
Masayuki Teramoto et al, Lipoprotein(a) and the continuum of carotid atherosclerosis from plaque initiation to luminal stenosis: the Suita Study, European Journal of Preventive Cardiology (2026). DOI: 10.1093/eurjpc/zwag443
Journal information: European Journal of Preventive Cardiology
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Elevated lipoprotein(a) is associated with the progression of carotid atherosclerosis (2026, October 8) retrieved 8 October 2026 from https://medicalxpress.com/news/2026-10-elevated-lipoproteina-carotid-atherosclerosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com